Why the study?
Does dabigatran etexilate improve efficacy and safety compared to warfarin in people with atrial fibrillation?
Does dabigatran etexilate improve efficacy and safety compared to warfarin in people with atrial fibrillation?
While dabigatran etexilate offers some benefits over warfarin for stroke prevention in atrial fibrillation, more evidence is needed regarding its long-term efficacy and safety.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Raju et al. (2010) conducted an editorial in Atrial fibrillation. Dabigatran etexilate vs. Warfarin was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: